Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1927 1
1928 1
1965 1
1970 1
1972 2
1976 2
1980 2
1984 3
1985 4
1986 4
1987 86
1988 231
1989 246
1990 231
1991 222
1992 291
1993 298
1994 327
1995 335
1996 311
1997 337
1998 367
1999 384
2000 444
2001 438
2002 571
2003 571
2004 580
2005 702
2006 779
2007 765
2008 824
2009 797
2010 936
2011 978
2012 1037
2013 1244
2014 1872
2015 2294
2016 2649
2017 2810
2018 2946
2019 3173
2020 3600
2021 3841
2022 3629
2023 1602

Text availability

Article attribute

Article type

Publication date

Search Results

37,636 results

Results by year

Filters applied: . Clear all
Page 1
Reactive oxygen species in cancer.
Liou GY, Storz P. Liou GY, et al. Free Radic Res. 2010 May;44(5):479-96. doi: 10.3109/10715761003667554. Free Radic Res. 2010. PMID: 20370557 Free PMC article. Review.
Elevated rates of reactive oxygen species (ROS) have been detected in almost all cancers, where they promote many aspects of tumour development and progression. However, tumour cells also express increased levels of antioxidant proteins to detoxify from ROS, suggesting tha …
Elevated rates of reactive oxygen species (ROS) have been detected in almost all cancers, where they promote many aspects of tumour d …
Clinical Trials and Progress in Metastatic Colon Cancer.
Mody K, Bekaii-Saab T. Mody K, et al. Surg Oncol Clin N Am. 2018 Apr;27(2):349-365. doi: 10.1016/j.soc.2017.11.008. Surg Oncol Clin N Am. 2018. PMID: 29496094 Review.
Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide but associated mortality has declined in recent decades. ...Further refinement based on molecular discoveries and the emergence of newer technologies to enable new discoveries allow for gr …
Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide but associated mortality has declined in recent …
Identifying and Meeting the Needs of Adolescents and Young Adults with Cancer.
Jin Z, Griffith MA, Rosenthal AC. Jin Z, et al. Curr Oncol Rep. 2021 Jan 15;23(2):17. doi: 10.1007/s11912-020-01011-9. Curr Oncol Rep. 2021. PMID: 33449203 Review.
PURPOSE OF REVIEW: Adolescents and young adults (AYAs) with cancer are a vulnerable population with unique needs that are under-recognized and often overlooked by healthcare providers. ...RECENT FINDINGS: Survival rates have not improved in adolescents and young adults wit …
PURPOSE OF REVIEW: Adolescents and young adults (AYAs) with cancer are a vulnerable population with unique needs that are under-recog …
Cancer in Sexual and Gender Minority Patients: Are We Addressing Their Needs?
Cathcart-Rake EJ. Cathcart-Rake EJ. Curr Oncol Rep. 2018 Sep 13;20(11):85. doi: 10.1007/s11912-018-0737-3. Curr Oncol Rep. 2018. PMID: 30209629 Review.
RECENT FINDINGS: Sexual and gender minorities suffer from cancer-related disparities, including lower rates of cancer screening, higher incidence of certain cancers, and higher cancer mortality rates. ...There is a paucity of literature guiding the …
RECENT FINDINGS: Sexual and gender minorities suffer from cancer-related disparities, including lower rates of cancer screenin …
Immunotherapies in rare cancers.
Vivekanandhan S, Bahr D, Kothari A, Ashary MA, Baksh M, Gabriel E. Vivekanandhan S, et al. Mol Cancer. 2023 Feb 1;22(1):23. doi: 10.1186/s12943-023-01720-2. Mol Cancer. 2023. PMID: 36726126 Free PMC article. Review.
Rare cancers comprise a group of about 200 cancers that individually occur at extremely low frequencies. ...However, combined their frequency of occurrence is much higher than any singular cancer. Cancer treatment and management has tremendously improv …
Rare cancers comprise a group of about 200 cancers that individually occur at extremely low frequencies. ...However, combined …
Dysplasia and Cancer in Inflammatory Bowel Disease.
Huang LC, Merchea A. Huang LC, et al. Surg Clin North Am. 2017 Jun;97(3):627-639. doi: 10.1016/j.suc.2017.01.010. Surg Clin North Am. 2017. PMID: 28501251 Review.
Inflammatory bowel disease is associated with an increased risk of dysplasia and cancer. Improvements in medical management and endoscopic surveillance have reduced these risks. Patients can develop cancer even in the absence of dysplasia or with indefinite or low-g …
Inflammatory bowel disease is associated with an increased risk of dysplasia and cancer. Improvements in medical management and endos …
Antibodies in cancer immunotherapy.
Karyampudi L, Knutson KL. Karyampudi L, et al. Cancer Biomark. 2010;6(5-6):291-305. doi: 10.3233/CBM-2009-0141. Cancer Biomark. 2010. PMID: 20938089 Review.
Monoclonal antibodies are currently being used as potential therapeutics against cancer. So far, eight monoclonal antibodies have been approved by FDA for human use and all these antibodies are effective in the treatment of patients with variety of cancers. ...Monoc …
Monoclonal antibodies are currently being used as potential therapeutics against cancer. So far, eight monoclonal antibodies have bee …
Cholangiocarcinoma--controversies and challenges.
Patel T. Patel T. Nat Rev Gastroenterol Hepatol. 2011 Apr;8(4):189-200. doi: 10.1038/nrgastro.2011.20. Nat Rev Gastroenterol Hepatol. 2011. PMID: 21460876 Free PMC article. Review.
Cholangiocarcinomas are a diverse group of tumors that are presumed to originate from the biliary tract epithelium either within the liver or the biliary tract. These cancers are often difficult to diagnose, their pathogenesis is poorly understood, and their dismal prognos …
Cholangiocarcinomas are a diverse group of tumors that are presumed to originate from the biliary tract epithelium either within the liver o …
Molecular diagnosis of intrahepatic cholangiocarcinoma.
Haga H, Patel T. Haga H, et al. J Hepatobiliary Pancreat Sci. 2015 Feb;22(2):114-23. doi: 10.1002/jhbp.156. Epub 2014 Sep 29. J Hepatobiliary Pancreat Sci. 2015. PMID: 25267595 Free PMC article. Review.
Intrahepatic cholangiocarcinomas (iCCA) are primary intrahepatic malignancies originating from biliary epithelia. While both hepatocellular cancer and iCCA can present as mass lesions within the liver, these cancers are distinct in their morphology, etiology, pathol …
Intrahepatic cholangiocarcinomas (iCCA) are primary intrahepatic malignancies originating from biliary epithelia. While both hepatocellular …
Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents.
Holtan SG, Creedon DJ, Haluska P, Markovic SN. Holtan SG, et al. Mayo Clin Proc. 2009 Nov;84(11):985-1000. doi: 10.1016/S0025-6196(11)60669-1. Mayo Clin Proc. 2009. PMID: 19880689 Free PMC article. Review.
Systemic alterations in immunity are also detectable, particularly with respect to a helper T cell type 2 polarization evident in advanced cancers and midtrimester pregnancy. This review summarizes the similarities between growth and immune privilege in cancer and p …
Systemic alterations in immunity are also detectable, particularly with respect to a helper T cell type 2 polarization evident in advanced …
37,636 results
You have reached the last available page of results. Please see the User Guide for more information.